ABL Bio Inc.
Bear Case (25th pct.)
-109.0% vs price
Base Case (Median)
-105.2% vs price
Bull Case (75th pct.)
-101.5% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-14183.06 | -112.7% | High (40%) |
| EV/FCF | $2434.64 | -97.8% | Medium (20%) |
Based on 2 out of 8 methods, 298380.KQ appears overvalued at the current price of $112000.00. The base case fair value of $-5874.21 implies 105.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.